Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4

Riccardo Gavioli, Michael G. Kurilla, Pedro O. De Campos-Lima, Lesley E. Wallace, Riccardo Dolcetti, Ruth J. Murray, Alan B. Rickinson, Maria G. Masucci

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

Epstein-Barr virus (EBV), a ubiquitous herpesvirus, induces potent HLA class I-restricted cytotoxic T-lymphocyte (CTL) responses. Analyses of target antigen choice have shown that the very strong CTL responses which are often observed through the HLA A11 allele map are due almost entirely to a single transformation-associated EBV protein, the nuclear antigen EBNA4. Here, we sought to determine the number and relative immunogenicities of HLA A11-restricted epitopes within this 938-amino-acid protein. An initial screening with a series of recombinant vaccinia virus vectors encoding progressively truncated forms of EBNA4 was followed by peptide sensitization experiments using overlapping 14- or 15-mers from the entire sequence. These two approaches allowed the identification of five epitope regions located between residues 101 and 115, 416 and 429, 396 and 410, 481 and 495, and 551 and 564 of the EBNA4 molecule. CTL preparations from all seven HLA A11-positive donors tested had demonstrable reactivities against the 416-to-429 peptide, whereas reactivities against the other epitopes either tended to be lost on serial passage or, for some of the donors, were never detected. The immunodominance of the 416-to-429 epitope was further supported by peptide dilution assays using polyclonal effectors and by CTL cloning experiments. Analysis of the 416-to-429 region identified the nanomer 416-424 (IVTDFSVIK) as the cognate peptide. This peptide was able to sensitize targets to lysis by A11-restricted CTL clones at concentrations as low as 5 × 10-14 M.

Original languageEnglish
Pages (from-to)1572-1578
Number of pages7
JournalJournal of Virology
Volume67
Issue number3
Publication statusPublished - Mar 1993

Fingerprint

HLA-A11 Antigen
nuclear antigens
Epstein-Barr Virus Nuclear Antigens
Human herpesvirus 4
cytotoxic T-lymphocytes
T-Lymphocyte Epitopes
Cytotoxic T-Lymphocytes
epitopes
immune response
peptides
Epitopes
Peptides
Serial Passage
Satellite Viruses
Vaccinia virus
Herpesviridae
Human Herpesvirus 4
Organism Cloning
molecular cloning
Proteins

ASJC Scopus subject areas

  • Immunology

Cite this

Gavioli, R., Kurilla, M. G., De Campos-Lima, P. O., Wallace, L. E., Dolcetti, R., Murray, R. J., ... Masucci, M. G. (1993). Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. Journal of Virology, 67(3), 1572-1578.

Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. / Gavioli, Riccardo; Kurilla, Michael G.; De Campos-Lima, Pedro O.; Wallace, Lesley E.; Dolcetti, Riccardo; Murray, Ruth J.; Rickinson, Alan B.; Masucci, Maria G.

In: Journal of Virology, Vol. 67, No. 3, 03.1993, p. 1572-1578.

Research output: Contribution to journalArticle

Gavioli, R, Kurilla, MG, De Campos-Lima, PO, Wallace, LE, Dolcetti, R, Murray, RJ, Rickinson, AB & Masucci, MG 1993, 'Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4', Journal of Virology, vol. 67, no. 3, pp. 1572-1578.
Gavioli, Riccardo ; Kurilla, Michael G. ; De Campos-Lima, Pedro O. ; Wallace, Lesley E. ; Dolcetti, Riccardo ; Murray, Ruth J. ; Rickinson, Alan B. ; Masucci, Maria G. / Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. In: Journal of Virology. 1993 ; Vol. 67, No. 3. pp. 1572-1578.
@article{8839631cd77642899bd075c406212e8c,
title = "Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4",
abstract = "Epstein-Barr virus (EBV), a ubiquitous herpesvirus, induces potent HLA class I-restricted cytotoxic T-lymphocyte (CTL) responses. Analyses of target antigen choice have shown that the very strong CTL responses which are often observed through the HLA A11 allele map are due almost entirely to a single transformation-associated EBV protein, the nuclear antigen EBNA4. Here, we sought to determine the number and relative immunogenicities of HLA A11-restricted epitopes within this 938-amino-acid protein. An initial screening with a series of recombinant vaccinia virus vectors encoding progressively truncated forms of EBNA4 was followed by peptide sensitization experiments using overlapping 14- or 15-mers from the entire sequence. These two approaches allowed the identification of five epitope regions located between residues 101 and 115, 416 and 429, 396 and 410, 481 and 495, and 551 and 564 of the EBNA4 molecule. CTL preparations from all seven HLA A11-positive donors tested had demonstrable reactivities against the 416-to-429 peptide, whereas reactivities against the other epitopes either tended to be lost on serial passage or, for some of the donors, were never detected. The immunodominance of the 416-to-429 epitope was further supported by peptide dilution assays using polyclonal effectors and by CTL cloning experiments. Analysis of the 416-to-429 region identified the nanomer 416-424 (IVTDFSVIK) as the cognate peptide. This peptide was able to sensitize targets to lysis by A11-restricted CTL clones at concentrations as low as 5 × 10-14 M.",
author = "Riccardo Gavioli and Kurilla, {Michael G.} and {De Campos-Lima}, {Pedro O.} and Wallace, {Lesley E.} and Riccardo Dolcetti and Murray, {Ruth J.} and Rickinson, {Alan B.} and Masucci, {Maria G.}",
year = "1993",
month = "3",
language = "English",
volume = "67",
pages = "1572--1578",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4

AU - Gavioli, Riccardo

AU - Kurilla, Michael G.

AU - De Campos-Lima, Pedro O.

AU - Wallace, Lesley E.

AU - Dolcetti, Riccardo

AU - Murray, Ruth J.

AU - Rickinson, Alan B.

AU - Masucci, Maria G.

PY - 1993/3

Y1 - 1993/3

N2 - Epstein-Barr virus (EBV), a ubiquitous herpesvirus, induces potent HLA class I-restricted cytotoxic T-lymphocyte (CTL) responses. Analyses of target antigen choice have shown that the very strong CTL responses which are often observed through the HLA A11 allele map are due almost entirely to a single transformation-associated EBV protein, the nuclear antigen EBNA4. Here, we sought to determine the number and relative immunogenicities of HLA A11-restricted epitopes within this 938-amino-acid protein. An initial screening with a series of recombinant vaccinia virus vectors encoding progressively truncated forms of EBNA4 was followed by peptide sensitization experiments using overlapping 14- or 15-mers from the entire sequence. These two approaches allowed the identification of five epitope regions located between residues 101 and 115, 416 and 429, 396 and 410, 481 and 495, and 551 and 564 of the EBNA4 molecule. CTL preparations from all seven HLA A11-positive donors tested had demonstrable reactivities against the 416-to-429 peptide, whereas reactivities against the other epitopes either tended to be lost on serial passage or, for some of the donors, were never detected. The immunodominance of the 416-to-429 epitope was further supported by peptide dilution assays using polyclonal effectors and by CTL cloning experiments. Analysis of the 416-to-429 region identified the nanomer 416-424 (IVTDFSVIK) as the cognate peptide. This peptide was able to sensitize targets to lysis by A11-restricted CTL clones at concentrations as low as 5 × 10-14 M.

AB - Epstein-Barr virus (EBV), a ubiquitous herpesvirus, induces potent HLA class I-restricted cytotoxic T-lymphocyte (CTL) responses. Analyses of target antigen choice have shown that the very strong CTL responses which are often observed through the HLA A11 allele map are due almost entirely to a single transformation-associated EBV protein, the nuclear antigen EBNA4. Here, we sought to determine the number and relative immunogenicities of HLA A11-restricted epitopes within this 938-amino-acid protein. An initial screening with a series of recombinant vaccinia virus vectors encoding progressively truncated forms of EBNA4 was followed by peptide sensitization experiments using overlapping 14- or 15-mers from the entire sequence. These two approaches allowed the identification of five epitope regions located between residues 101 and 115, 416 and 429, 396 and 410, 481 and 495, and 551 and 564 of the EBNA4 molecule. CTL preparations from all seven HLA A11-positive donors tested had demonstrable reactivities against the 416-to-429 peptide, whereas reactivities against the other epitopes either tended to be lost on serial passage or, for some of the donors, were never detected. The immunodominance of the 416-to-429 epitope was further supported by peptide dilution assays using polyclonal effectors and by CTL cloning experiments. Analysis of the 416-to-429 region identified the nanomer 416-424 (IVTDFSVIK) as the cognate peptide. This peptide was able to sensitize targets to lysis by A11-restricted CTL clones at concentrations as low as 5 × 10-14 M.

UR - http://www.scopus.com/inward/record.url?scp=0027464975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027464975&partnerID=8YFLogxK

M3 - Article

VL - 67

SP - 1572

EP - 1578

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 3

ER -